Ginkgetin for COVID-19
Ginkgetin has been reported as potentially beneficial for treatment of COVID-19. We have not reviewed these studies. See all other treatments.
Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets, Pharmaceutical Biology, doi:10.1080/13880209.2023.2241518 ,
In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2023.101278 ,
Critical Review of Plant-Derived Compounds as Possible Inhibitors of SARS-CoV-2 Proteases: A Comparison with Experimentally Validated Molecules, ACS Omega, doi:10.1021/acsomega.2c05766 ,
Computational investigation of natural compounds as potential main protease (Mpro) inhibitors for SARS-CoV-2 virus, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.106318 ,
Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432 ,
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.